M
Milos Dokmanovic
Researcher at Center for Drug Evaluation and Research
Publications - 25
Citations - 4315
Milos Dokmanovic is an academic researcher from Center for Drug Evaluation and Research. The author has contributed to research in topics: Trastuzumab & Cell growth. The author has an hindex of 18, co-authored 25 publications receiving 4037 citations. Previous affiliations of Milos Dokmanovic include University of Illinois at Chicago & Memorial Sloan Kettering Cancer Center.
Papers
More filters
Journal ArticleDOI
Histone Deacetylase Inhibitors: Overview and Perspectives
TL;DR: This review focuses on the activities of the 11 zinc-containing HDACs, their histone and nonhistone protein substrates, and the different pathways by which HDACi induce transformed cell death.
Journal Article
A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents
Bey-Dih Chang,Eugenia V. Broude,Milos Dokmanovic,Hongming Zhu,Adam Ruth,Yongzhi Xuan,Eugene S. Kandel,Ekkehart Lausch,Konstantin Christov,Igor B. Roninson +9 more
TL;DR: SLP induction in breast carcinoma cells treated with retinoids in vitro or in vivo was found to correlate with permanent growth inhibition under the conditions of minimal cytotoxicity, suggesting that this response may be particularly important for the antiproliferative effect of differentiating agents.
Journal ArticleDOI
Prospects: histone deacetylase inhibitors.
Milos Dokmanovic,Paul A. Marks +1 more
TL;DR: This review focuses on several key questions with respect to the mechanism of action of HDACi, including, what are the different cell phenotypes induced by HDAC i, why are normal cells compared to transformed cells relatively resistant toHDACi induced cell death, why is certain tumors more responsive to HDACs than others, and what is the basis of the selectivity of HDaci in altering gene expression.
Journal ArticleDOI
Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors
J. S. Ungerstedt,Y. Sowa,Weisheng Xu,Y. Shao,Milos Dokmanovic,G. Perez,Lang Ngo,Arne Holmgren,X. Jiang,Paul A. Marks +9 more
TL;DR: It is found that the HDACi suberoylanilide hydroxamic acid (SAHA) and MS-275, a benzamide, cause an accumulation of reactive oxygen species (ROS) and caspase activation in transformed but not normal cells.
Journal ArticleDOI
Histone sumoylation is a negative regulator in Saccharomyces cerevisiae and shows dynamic interplay with positive-acting histone modifications
Dafna Nathan,Kristin Ingvarsdottir,David E. Sterner,Gwendolyn R. Bylebyl,Milos Dokmanovic,Jean Dorsey,Kelly A. Whelan,Mihajlo L. Krsmanovic,William S. Lane,Pamela B. Meluh,Erica S. Johnson,Shelley L. Berger +11 more
TL;DR: Evidence is provided that histone sumoylation is the first negative histone modification to be identified in S. cerevisiae and it is suggested thatsumoylation may serve as a general dynamic mark to oppose transcription.